Indian Pharma Firms to Launch Diabetes medicine at 90% Lower Cost

A number of Indian pharmaceutical companies are getting ready to release much more affordable generic versions of the diabetes medication empagliflozin. The action comes after Boehringer Ingelheim's patent expired, according to the sources.

Zydus Secures FDA Nod for Ketoconazole Shampoo Manufacturing

Zydus Lifesciences Limited has acquired final permission from the US Food and Drug Administration (USFDA) to manufacture 2% ketoconazole shampoo. According to the company's release today.

Glenmark Pharma launches osmotic laxative Polyethylene Glycol in the U.S.

Glenmark Pharmaceuticals have a presence in more than 80 countries, and the US market will see the introduction of Polyethylene Glycol 3350 Powder for Solution as an over-the-counter product...

States to Set Up Centers for BioE3 Policy Implementation: Union Minister

Union Minister Jitendra Singh announced the establishment of BioE3 Cells in states to function as interconnected knowledge centers that will nurture the biomanufacturing sector of India. BioE3 Cells positioned between state and national stakeholders

ICMR Launches "Patent Mitra" to Boost Biomedical Innovations

The Medical Innovations Patent Mitra has been launched by The Indian Council of Medical Research (ICMR) to enhance India’s healthcare innovation and patent ecosystem. Ensuring that biomedical research transla...

Sun Pharma to acquire Checkpoint Therapeutics for $355 Million

On Monday, March 10, Sun Pharmaceuticals Industries Ltd. announced its plans to acquire Nasdaq-listed Checkpoint Therapeutics, Inc., which specializes in...

Greater Exploration Needed in Aerospace Medicine: Defence Minister

Minister of Defence Rajnath Singh today visited the Institute of Aerospace Medicine (IAM) of the Indian Air Force (IAF) in Bengaluru, where he met with the officers from the IAF. He drew attention to the increasing

Lupin Introduces Rivaroxaban Generic for Cardiovascular Treatment in USA

Lupin Ltd has rolled out the reviroxaban tablet, 2.5 mg, in the US market. This comes after the FDA gave its final nod to the company's abbreviated new drug application on March 7. The product matches the generic version...

Biocon Biologics and Civica partner to expand U.S. Insulin Aspart access

Civica, a non-profit generic drug and pharmaceutical company established in 2018 to address and resolve life-saving drug shortages and affordability, and Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Bioc

India & Belgium collaborate to Boost RNA-Based Vaccine Innovation

Belgium-based Quantoom Biosciences (Quantoom) and TechInvention Lifecare Pvt. Ltd. (TechInvention) have launched a strategic partnership. In the presence of Her Royal Highness Princess Astrid of Belgium, business executives, and important...

© 2025 India Pharma Outlook. All Rights Reserved.